歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > PI3K/Akt/mTORsignaling > XL-147

瀏覽歷史

S81118

XL-147

源葉(MedMol) 98%
  • 英文名:
  • XL-147
  • 別名:
  • CAS號:
  • 934526-89-3
  • 分子式:
  • C25H25ClN6O4S
  • 分子量:
  • 541.02
  • 核磁/質譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S81118-2mg 98% ¥297.50元 9 - - - EA 加入購物車
源葉(MedMol) S81118-5mg 98% ¥501.50元 7 - - - EA 加入購物車
源葉(MedMol) S81118-10mg 98% ¥977.50元 7 - - - EA 加入購物車
源葉(MedMol) S81118-25mg 98% ¥1615.00元 5 - - - EA 加入購物車
源葉(MedMol) S81118-50mg 98% ¥2450.00元 預計交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S81118-100mg 98% ¥3900.00元 預計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質檢證書(COA)

摩爾濃度計算器

相關產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Pilaralisib (XL147; SAR245408) is a potent and highly selective class I PI3Ks inhibitor with IC50s of 39 nM, 383 nM, 23 nM and 36 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ.
  • 靶點: PI3Kα:39 nM (IC50);PI3Kβ:383 nM (IC50);PI3Kδ:36 nM (IC50);PI3Kγ:23 nM (IC50);Vps34:6974 nM (IC50);DNA-PK:4750 nM (IC50);PI3K
  • 體內(nèi)研究:
    The ability of Pilaralisib (XL147) to inhibit this endogenous phosphorylation of AKT, p70S6K, and S6 is examined following a single oral dose of 10, 30, 100, or 300 mg/kg. The tumors are harvested 4, 24, or 48 hours postdose and homogenized in lysis buffer. Tumor lysates from each animal (n=4) are then pooled for each group and analyzed for levels of total and phosphorylated AKT, p70S6K, and S6 by Western immunoblotting. Administration of Pilaralisib (XL147) causes a dose-dependent decrease in phosphorylation of AKT, p70S6K, and S6 in the tumors, reaching a maximum of 81% inhibition of AKT phosphorylation at 300 mg/kg at 4 hours. The dose-response relationships derived from the 4-hour time point predict 50% inhibition of AKT, p70S6K, and S6 phosphorylation at doses of approximately 100 mg/kg (pAKTT308), 54 mg/kg (pAKTS473), 71 mg/kg (p-p70S6K), and 103 mg/kg (pS6). The inhibition of AKT, p70S6K, and S6 phosphorylation in MCF7 tumors following a 100 mg/kg dose of Pilaralisib (XL147) is maximal at 4 hours, reaching 55% to 75%; however, the level of inhibition decreased to 8% to 45% by 24 hours, and only minimal or no inhibition was evident by 48 hours. Following a 300 mg/kg dose of Pilaralisib (XL147), inhibition is also maximal at 4 hours (65%-81%). However, in contrast with the 100 mg/kg dose, inhibition at 24 hours (51%-78%) is almost comparable with that seen at 4 hours, and partial inhibition (25%-51%) persisted through 48 hours
  • 參考文獻:
    1. Foster P, et al. The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models. Mol Cancer Ther. 2015 Apr;14(4):931-40.
  • 溶解性: DMSO  :  ≥  100  mg/mL  (184.84  mM)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.848 ml 9.242 ml 18.484 ml
    5 mM 0.37 ml 1.848 ml 3.697 ml
    10 mM 0.185 ml 0.924 ml 1.848 ml
    50 mM 0.037 ml 0.185 ml 0.37 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:


質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。